The increasing demand for donated blood, the rising number of
blood donations, the growing prevalence of infectious diseases, and the
increasing prevalence of newer pathogens are the key factors driving the growth
of this market.
The
Blood Screening
Market is projected to reach USD 3.5 billion by 2025
from USD 1.9 billion in 2020, at a CAGR of 12.8%.
Based on product & service, the blood screening market is
segmented into reagents and kits, instruments, and software and services. The
reagents and kits segment accounted for the largest share of the blood
screening market in 2019. The large share of this segment can be attributed to
the high consumption and repeated use of reagents & kits in blood screening
procedures. Also, the accessibility of a wide range of reagents and the need
for reliable, specific, and fast detection of TTIs are driving the growth of
the blood screening reagents & kits market.
Based
on end users, the blood screening market is segmented into blood banks and
hospitals. The blood bank segment accounted for the larger market share in 2019
and is projected to witness a higher growth rate during the forecast period.
This can be attributed to the increasing demand for donated blood, a growing
number of organ transplantation surgeries, rising awareness regarding the
safety of blood, an increasing number of donations worldwide, and growth in
government funding to charitable trusts.
Based
on region, the blood screening market is segmented into North America, Europe, the
Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North
America accounted for the largest market share, followed by Europe.
The
prominent players operating in the blood screening market include Grifols
(Spain), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (US),
BioMérieux (France), Bio-Rad Laboratories (US), Siemens Healthineers (Germany),
Danaher Corporation (US), Thermo Fisher Scientific Inc. (US) ,Ortho Clinical
Diagnostics, Inc.(US), Becton, Dickinson and Company (US), DiaSorin (Italy),
GFE (Germany), Trinity Biotech (Ireland), Merck Millipore (Germany), GE
Healthcare (US), Perkin Elmer (US), Bio-Techne Corporation (US), and J Mitra
& Co. Pvt. Ltd (India).
No comments:
Post a Comment